Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
Cell Transplant ; 12(6): 627-35, 2003.
Article in English | MEDLINE | ID: mdl-14579931

ABSTRACT

After pancreatic islet transplantation, insufficient blood supply is responsible for the loss of islet viability. The aim of our study was: 1) to determine the influence of vascular endothelial growth factor (VEGF) on the survival of encapsulated rat islets transplanted into healthy and diabetic mice and 2) to evaluate the metabolic efficiency of the VEGF-supplemented grafts. Twenty-four hours after culture, 50 rat islets immobilized into collagen in the presence of VEGF (100 ng/ml) and encapsulated (AN69 membrane, HOSPAL) were grafted in the peritoneal cavity of healthy or streptozotocin-induced diabetic mice (n = 6). Seven, 14, and 28 days after implantation, the encapsulation device and tissue surrounding the device were removed and the following parameters were analyzed: the number and the diameter of buds, the distance between devices and buds, the amount of cellular adhesion on the capsule surface, and the level of insulin secreted by encapsulated islet. For reversal of diabetes, 1000 rat islets encapsulated in the presence of VEGF were implanted in the peritoneal cavity of diabetic mice and fasting glycemia was analyzed. After 7 days of islet implantation in the absence of VEGF, the bud diameter was 16.1 +/- 6.9 microm in diabetic mice and 34.4 +/- 3.9 microm in healthy mice. However, the number of buds increased by a factor 2.5 in the presence of VEGF in both types of mice. Furthermore, when islets were transplanted in the presence of VEGF, the distance between the device and the buds was significantly decreased in both types of mice (p < 0.001) after 7, 14, and 28 days of islet implantation. Capsule analysis showed a decrease in cellular adhesion when the islets were encapsulated in the presence of VEGF. Insulin secretion of the islets was higher in the presence of VEGF compared with islets alone at all steps of the study. When 1000 rat islets were transplanted in the presence of VEGF, the glycemia level decreased to 6.2 +/- 0.8 mmol/L after 3 days and remained stable until at least 28 days. In contrast, in the absence of VEGF, the initial decrease in the glucose level was rapidly followed by a relapse in hyperglycemia. In summary, VEGF increased the viability of engrafted encapsulated islets, increasing the duration of a normalized glycemia in diabetic mice following transplantation. Local adjunction of VEGF may therefore improve the clinical outcome of islet transplantation.


Subject(s)
Diabetes Mellitus, Experimental/therapy , Graft Survival/drug effects , Islets of Langerhans Transplantation/methods , Islets of Langerhans/drug effects , Transplantation, Heterologous/methods , Vascular Endothelial Growth Factor A/pharmacology , Animals , Blood Glucose/drug effects , Blood Glucose/metabolism , Cell Adhesion/drug effects , Cell Adhesion/physiology , Cell Division/drug effects , Cell Division/physiology , Disease Models, Animal , Graft Survival/physiology , Insulin/metabolism , Insulin Secretion , Islets of Langerhans/blood supply , Islets of Langerhans/physiology , Mice , Microcirculation/drug effects , Microcirculation/physiology , Neovascularization, Physiologic/drug effects , Neovascularization, Physiologic/physiology , Peritoneum/cytology , Peritoneum/physiology , Peritoneum/surgery , Rats , Vascular Endothelial Growth Factor A/therapeutic use
2.
J Vasc Res ; 40(4): 359-67, 2003.
Article in English | MEDLINE | ID: mdl-12891005

ABSTRACT

Transplantation of pancreatic islets is proposed as a treatment for type 1 diabetes, but insufficient blood supply can cause the loss of viable grafted islets. In the present study, we investigated the influence of vascular endothelial growth factor (VEGF) on the angiogenesis of omentum during encapsulated islet allotransplantation and consequently on islet survival. Fifty rat islets, cultured for 24 h, were encapsulated in the presence or absence of human VEGF and implanted in the peritoneal cavity of rats (n = 6). After 7, 14 and 28 days of implantation, encapsulation devices with surrounding omentum were removed. Histological analysis of this tissue was performed. Cellular adhesion at the membrane surface was characterized by a phagocytosis test. The morphological aspect of the islets was analyzed and their functionality was evaluated by measuring insulin secretion. At each step of the study, there was a two-fold increase in the number of vessels in the presence of VEGF. In addition, VEGF increased the vessel diameter and the surface area of the angiogenic pedicle. Moreover, the presence of VEGF significantly decreased the distance between the devices and vessels (16.2 +/- 5.6 vs. 51.6 +/- 10.1 microm, p < 0.001). Membrane surface analysis showed a decrease in macrophage adhesion in the presence of VEGF. Furthermore, islet structure and functionality was preserved in the presence of VEGF. Stimulation of angiogenesis of omentum induced by VEGF is associated with preservation of islet viability. Local delivery of VEGF proved to be a relevant approach to ameliorate the outcome of islet transplantation.


Subject(s)
Endothelial Growth Factors/pharmacology , Intercellular Signaling Peptides and Proteins/pharmacology , Islets of Langerhans Transplantation/methods , Islets of Langerhans/blood supply , Lymphokines/pharmacology , Neovascularization, Physiologic/drug effects , Omentum/blood supply , Animals , Cell Survival/physiology , Cells, Cultured , Cells, Immobilized/cytology , Cells, Immobilized/transplantation , Diabetes Mellitus, Type 1/surgery , Drug Compounding , Graft Survival , Islets of Langerhans/cytology , Rats , Rats, Wistar , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
3.
Arch Mal Coeur Vaiss ; 96(7-8): 808-10, 2003.
Article in French | MEDLINE | ID: mdl-12945230

ABSTRACT

Spironolactone, a diuretic antagonist of aldosterone has an unexplained side effect of amenorrhea which could be due to an angiogenesis inhibition. In this study we compared the effects of spironolactone, canrenone an active metabolite of spironolactone and eplerenone a more selective mineralocorticoid antagonist in rats implanted with a fibrin gel chamber. Perforated plexiglass chambers filled with rat fibrin, spironolactone (50 microM), canrenone (100 microM), eplerenone (500 microM), DMSO (0.05%) and control were implanted into the dorsal subcutaneous space of wistar rats. After 14 days of implantation, an invasion of the fibrin gel chamber by neovascularised buds had occurred through the holes. The number of vessels in the central field and in two or three peripheral fields covering the surface of the bud, were measured for each drug tested and compared to the control. In spironolactone treated chambers, the numbers of peripheral and central vessels were significantly reduced compared to control (p < 0.001). Canrenone, eplerenone and DMSO did not reduce the number of vessels (m +/- ESM, ANOVA followed by Newman-Keuls test). Spironolactone but not canrenone, nor eplerenone inhibited vessels formation in vivo. This antiangiogenic activity appeared to be not related to the antimineralocorticoid effect of spironolactone.


Subject(s)
Amenorrhea/chemically induced , Canrenone/adverse effects , Canrenone/pharmacology , Mineralocorticoid Receptor Antagonists/adverse effects , Mineralocorticoid Receptor Antagonists/pharmacology , Neovascularization, Physiologic/drug effects , Spironolactone/analogs & derivatives , Spironolactone/adverse effects , Spironolactone/pharmacology , Amenorrhea/physiopathology , Animals , Canrenone/administration & dosage , Eplerenone , Female , Fibrin , Humans , Hypertension/drug therapy , Mineralocorticoid Receptor Antagonists/administration & dosage , Rats , Spironolactone/administration & dosage
4.
Int J Cancer ; 94(1): 44-53, 2001 Oct 01.
Article in English | MEDLINE | ID: mdl-11668477

ABSTRACT

Laminins represent a growing family of glycoproteins constituting the basement membrane. They are known to direct many biological processes. With respect to carcinogenesis, laminins play an important role in cell adhesion, mitogenesis, differentiation and even metastasis. To further study the biological significance of laminin-1 (composed of alpha1, beta1 and gamma1 chains) in intestinal cell differentiation or tumorigenesis, an alpha1-laminin expression vector was introduced into the HT29 colonic cancer cells, in which laminin alpha1 chain is not expressed. Upon transfection of the alpha1 chain, the alpha1beta1gamma1 trimer was found secreted in the media along with free alpha1 chain as assessed by immunoprecipitation. The presence of the laminin alpha1 chain did not significantly modify the levels of the other laminin chains nor the integrins expressed by the HT29 cells. In spite of similar growth properties with the control cells in vitro (plastic dish, soft agar), the laminin alpha1 transfectants showed a significantly increased tumor growth when injected in nude mice. Histologic and immunohistochemic examination of the laminin alpha1-expressing tumors points to an increased recruitment of the host stromal and vascular cells, without modification in the differentiation profile and invasion potential. In parallel, a clear accumulation of laminin-10 (alpha5beta1gamma1) at the carcinoma/stromal interface and a segregation of the integrin beta4 subunit at the basal pole of the cancer cells occurred, compared to control tumors. Overall, our observations emphasize the importance of laminin-1 as a chemoattractant of both stromal and vascular cells and in epithelial/stromal cell interactions for the organization of the basement membrane and segregation of integrins leading to an epithelial cell growth signal. Such a sequence of events is reminiscent of what occurs during development.


Subject(s)
Colonic Neoplasms/pathology , Laminin/physiology , Animals , Cell Division , Colonic Neoplasms/metabolism , HT29 Cells , Humans , Laminin/analysis , Mice , Neoplasm Transplantation , Rabbits , Transfection , Transplantation, Heterologous
5.
Ann Pathol ; 21(3): 215-32, 2001 Jun.
Article in French | MEDLINE | ID: mdl-11468559

ABSTRACT

Good self-knowledge enables us to have a well- reasoned adaptation to our environment. Starting from this precept based on simple common sense, activity and cost analysis, when applied to medical departments in a university hospital setting, represents a necessary phase in their scientific progression and in the continuation of their university vocation. This is all the more true given the present climate of economic and organizational restructuring of medical facilities. This paper relates the experience of a French surgical pathology department which was assessed for cost effectiveness using the Activity-Based Costing (ABC) method in 1999. This method, which originated in the business world and of which the general concepts are presented here, has given us a keener understanding of the diverse processes involved, their costs and how these costs are arrived at. Moreover, this method has identified the proportion of costs imputable to diagnostic work and of those linked to work specific to a university hospital, in particular teaching and research and development. The results can then be used for a clearer analysis of the figures required by prescribers and health care funding agencies, and, within the department, to enhance perception of work carried out by the entire staff in order to initiate a new type of management centered on activity (Activity-Based Management). Adaptable to any medical department, whatever its organizational structure, independent of the significance of any given code letter and regardless of the rating method used to grade activities, the ABC method also allows for comparisons between structures of a similar nature. The thoughts it inspires on economic performance must take into account the rules of good medical practice, the imperatives of quality assurance, the need for "breathing space" which are indispensable to research and a humanist conception of working relations.


Subject(s)
Costs and Cost Analysis/methods , Pathology, Surgical/economics , Diagnosis , France , Hospitals, University , Humans
6.
Circ Res ; 88(5): 468-75, 2001 Mar 16.
Article in English | MEDLINE | ID: mdl-11249869

ABSTRACT

Gene transfer with adenoviral vectors is an attractive approach for the treatment of atherosclerosis and restenosis. However, because expression of a therapeutic gene in nontarget tissues may have deleterious effects, artery-specific expression is desirable. Although expression vectors containing transcriptional regulatory elements of genes expressed solely in smooth muscle cells (SMCs) have proved efficient to restrict expression of the transgene, their use in the clinical setting can be limited by their reduced strength. In the present study, we show that low levels of transgene expression are obtained with the smooth muscle (SM)-specific SM22alpha promoter compared with the viral cytomegalovirus (CMV) enhancer/promoter. We have generated chimeric transcriptional cassettes containing either a SM (SM-myosin heavy chain) or a skeletal muscle (creatine kinase) enhancer combined with the SM22alpha promoter. With both constructs we observed significantly stronger expression that remains SM-specific. In vivo, reporter gene expression was restricted to arterial SMCs with no detectable signal at remote sites. Moreover, when interferon-gamma expression was driven by one of these two chimeras, SMC growth was inhibited as efficiently as with the CMV promoter. Finally, we demonstrate that neointima formation in the rat carotid balloon injury model was reduced to the same extent by adenoviral gene transfer of interferon-gamma driven either by the SM-myosin heavy chain enhancer/SM22alpha promoter or the CMV promoter. These results indicate that such vectors can be useful for the treatment of hyperproliferative vascular disorders.


Subject(s)
Enhancer Elements, Genetic/genetics , Muscle Proteins/genetics , Muscle, Smooth, Vascular/metabolism , Promoter Regions, Genetic/genetics , Adenoviridae/genetics , Animals , Cardiovascular Diseases/genetics , Cardiovascular Diseases/therapy , Carotid Arteries/metabolism , Cell Differentiation , Cell Division , Cell Line , Cells, Cultured , Cytomegalovirus/genetics , Gene Expression , Gene Transfer Techniques , Genetic Therapy , Genetic Vectors/genetics , Green Fluorescent Proteins , Humans , Interferon-gamma/genetics , Interferon-gamma/metabolism , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Mice , Mice, Inbred C57BL , Microfilament Proteins/genetics , Muscle, Smooth, Vascular/cytology , Myosin Heavy Chains/genetics , Rats , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Sensitivity and Specificity , Tumor Cells, Cultured , Tunica Intima/metabolism
7.
Ann Pathol ; 20(3): 275-9, 2000 May.
Article in French | MEDLINE | ID: mdl-10891733

ABSTRACT

Large block macrosectioning of segmental excision specimens for breast cancer, and especially ductal carcinoma in situ, provides detailed information regarding size of the lesions, extent of spread and margin status which are essential for local recurrence risk assessment. However, the expansion of this technique has been curbed due to its reputation of being technically difficult, time-consuming, costly and providing slides of poor quality. We assessed the feasibility of the large section technique and adapted it to the everyday practice of a routine pathology laboratory. The time spent cutting a large block on a motorized microtome is half the time spent cutting the great number of conventional blocks needed to assess the same amount of tissue. Finally, 4 mm-thick stained large preparations of high quality are produced within 3 days after receiving the specimen. Analysis and report are both more precise and easier since the pathologist is saved the trouble of having to mentally re-assemble a great quantity of numbered small blocks. 805 primary monobloc segmental excision specimens have been examined in this way over the last 50 months period and we advocate its use as a standard procedure for breast-conserving surgery specimen management.


Subject(s)
Breast Neoplasms/pathology , Breast Neoplasms/surgery , Histocytological Preparation Techniques , Mastectomy, Segmental , Female , Humans , Microtomy
8.
Int J Cancer ; 82(2): 208-12, 1999 Jul 19.
Article in English | MEDLINE | ID: mdl-10389754

ABSTRACT

Matrix metalloproteinase 2 (MMP2) activity is associated with the aggressiveness of human cancers. Therefore, the mechanisms regulating its activation are of great interest for a better understanding of malignant invasive processes. MT1-MMP, a membrane-bound MMP, is involved in the conversion of the latent form of MMP2 to the active one. In the present study, we have raised 3 monoclonal antibodies (Mabs) directed against 3 different epitopes of human MT1-MMP, which we used to investigate the expression and cellular localization of MT1-MMP protein in human carcinomas. MT1-MMP protein was present in all invasive carcinomas tested, and it was almost exclusively located to the stromal cells and not to cancer cells as previously reported, suggesting that MMP2 activation might be a peri-fibroblastic event.


Subject(s)
Breast Neoplasms/enzymology , Carcinoma/enzymology , Fibroblasts/enzymology , Metalloendopeptidases/analysis , Neoplasm Invasiveness , Neoplasm Proteins/analysis , Animals , Antibodies, Monoclonal/immunology , Breast Neoplasms/pathology , COS Cells , Carcinoma/pathology , Carcinoma, Ductal, Breast/enzymology , Carcinoma, Ductal, Breast/pathology , Carcinoma, Lobular/enzymology , Carcinoma, Lobular/pathology , Enzyme Activation , Enzyme Induction , Epitopes/immunology , Female , Humans , Immunoenzyme Techniques , Matrix Metalloproteinase 14 , Matrix Metalloproteinases, Membrane-Associated , Metalloendopeptidases/immunology , Mice , Mice, Inbred BALB C , Neoplasm Proteins/immunology , Recombinant Proteins/immunology , Stromal Cells/enzymology , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...